POGRX
Price
$42.26
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
RGAHX
Price
$81.03
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

POGRX vs RGAHX

Header iconPOGRX vs RGAHX Comparison
Open Charts POGRX vs RGAHXBanner chart's image
PRIMECAP Odyssey Growth
Price$42.26
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$81.03
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
POGRX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
POGRX vs. RGAHX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is POGRX is a Buy and RGAHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 306B vs. POGRX (6.12B). RGAHX pays higher dividends than POGRX: RGAHX (0.64) vs POGRX (0.44). POGRX was incepted earlier than RGAHX: POGRX (20 years) vs RGAHX (9 years). RGAHX is a more actively managed with annual turnover of: 31.00 vs. POGRX (7.00). RGAHX has a lower initial minimum investment than POGRX: RGAHX (250) vs POGRX (2000). RGAHX annual gain was more profitable for investors over the last year : 31.44 vs. POGRX (10.49). RGAHX return over 5 years is better than : 57.44 vs. POGRX (3.06).
POGRXRGAHXPOGRX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years9 years-
Gain YTD15.02429.96050%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets6.12B306B2%
Annual Yield % from dividends0.440.6469%
Returns for 1 year10.4931.4433%
Returns for 3 years-18.63-1.171,589%
Returns for 5 years3.0657.445%
Returns for 10 years63.66N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBIO24.790.17
+0.69%
BridgeBio Pharma
CSGP75.770.36
+0.48%
CoStar Group
FKWL4.400.01
+0.23%
Franklin Wireless Corp
VIR8.98-0.27
-2.92%
Vir Biotechnology
TLS3.71-0.21
-5.36%
Telos Corp